Synthetic cannabinoid receptor agonists are monoamine oxidase-A selective inhibitors.
Hindson SA, Andrews RC, Danson MJ, van der Kamp MW, Manley AE, Sutcliffe OB, Haines TSF, Freeman TP, Scott J, Husbands SM, Blagbrough IS, Anderson JLR, Carbery DR, Pudney CR.
Hindson SA, et al. Among authors: scott j.
FEBS J. 2023 Jun;290(12):3243-3257. doi: 10.1111/febs.16741. Epub 2023 Feb 21.
FEBS J. 2023.
PMID: 36708234
Free PMC article.